Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Elizabeth McFarland

Concepts (381)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV-1
26
2025
864
2.870
Why?
HIV Infections
48
2025
2836
2.850
Why?
Respiratory Syncytial Virus Vaccines
6
2022
36
2.350
Why?
Respiratory Syncytial Virus Infections
6
2022
128
2.150
Why?
Respiratory Syncytial Virus, Human
6
2022
74
2.140
Why?
Infectious Disease Transmission, Vertical
18
2025
184
2.100
Why?
HIV Antibodies
12
2025
62
2.040
Why?
Anti-Retroviral Agents
12
2023
233
1.740
Why?
Viral Proteins
3
2020
342
1.570
Why?
Antibodies, Viral
8
2022
625
1.130
Why?
Antibodies, Neutralizing
8
2025
286
1.090
Why?
Colonography, Computed Tomographic
3
2024
8
0.970
Why?
Anti-HIV Agents
11
2025
778
0.870
Why?
Antibodies, Monoclonal
6
2025
1430
0.870
Why?
AIDS Vaccines
8
2018
52
0.850
Why?
Pregnancy Complications, Infectious
8
2016
394
0.750
Why?
Gene Deletion
2
2020
391
0.730
Why?
Breast Feeding
4
2025
440
0.650
Why?
Atazanavir Sulfate
2
2017
41
0.640
Why?
HIV Protease Inhibitors
2
2017
69
0.620
Why?
Ritonavir
2
2017
74
0.620
Why?
Vaccination
6
2020
1381
0.580
Why?
HIV Envelope Protein gp120
6
2017
60
0.580
Why?
Vaccines, Attenuated
6
2022
132
0.580
Why?
Infant, Newborn
23
2025
6079
0.570
Why?
Incidental Findings
1
2018
87
0.550
Why?
Radiation Dosage
1
2018
179
0.510
Why?
Infant
31
2025
9465
0.510
Why?
Nelfinavir
1
2016
9
0.510
Why?
Lopinavir
1
2016
30
0.500
Why?
Syncope
1
2016
52
0.500
Why?
Bradycardia
1
2016
55
0.490
Why?
Patient Dropouts
1
2016
67
0.490
Why?
Lyme Disease
1
2016
60
0.480
Why?
Health Resources
1
2016
120
0.460
Why?
Infant, Newborn, Diseases
1
2016
113
0.450
Why?
HIV
5
2014
234
0.420
Why?
Patient Compliance
2
2018
581
0.400
Why?
Immunogenicity, Vaccine
4
2021
30
0.390
Why?
Referral and Consultation
1
2018
786
0.380
Why?
Child
37
2025
21935
0.380
Why?
Humans
74
2025
137585
0.370
Why?
T-Lymphocytes, Cytotoxic
4
2005
173
0.360
Why?
CD4-Positive T-Lymphocytes
2
2017
1091
0.360
Why?
Virus Replication
4
2020
483
0.350
Why?
Female
48
2025
73304
0.340
Why?
Lymphocyte Activation
5
2017
1142
0.310
Why?
Male
39
2025
67762
0.300
Why?
Adolescent
27
2025
21513
0.280
Why?
Viral Load
9
2017
466
0.280
Why?
HIV Seropositivity
2
2023
125
0.280
Why?
Bone Density
2
2025
489
0.270
Why?
Double-Blind Method
3
2020
1993
0.260
Why?
RNA, Viral
8
2023
656
0.250
Why?
Antibodies, Bacterial
2
2018
146
0.240
Why?
Antiretroviral Therapy, Highly Active
6
2017
271
0.230
Why?
Dyslipidemias
2
2017
176
0.230
Why?
Bone Development
1
2025
54
0.230
Why?
Immunoenzyme Techniques
1
2005
219
0.220
Why?
Immunoglobulin G
3
2022
893
0.220
Why?
Viremia
3
2011
138
0.220
Why?
Diverticulum
1
2024
12
0.220
Why?
Gene Products, gag
2
1994
36
0.210
Why?
Mammography
1
2025
154
0.210
Why?
Child, Preschool
21
2022
11074
0.210
Why?
Young Adult
12
2021
13209
0.200
Why?
Squalene
3
2017
7
0.200
Why?
Pregnancy
11
2023
6763
0.200
Why?
Complementarity Determining Regions
1
2002
51
0.190
Why?
Drug Resistance, Viral
2
2016
116
0.190
Why?
CD4 Lymphocyte Count
4
2017
269
0.190
Why?
Half-Life
1
2021
164
0.180
Why?
Growth Differentiation Factor 15
1
2021
40
0.180
Why?
Mitochondrial Diseases
1
2021
91
0.180
Why?
Immunization Schedule
2
2018
197
0.170
Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2002
336
0.170
Why?
Fibroblast Growth Factors
1
2021
172
0.170
Why?
Drug Therapy, Combination
4
2017
1066
0.170
Why?
T-Lymphocytes
2
2009
1996
0.170
Why?
RNA, Small Untranslated
1
2020
16
0.170
Why?
env Gene Products, Human Immunodeficiency Virus
2
2017
16
0.160
Why?
Hydrophobic and Hydrophilic Interactions
1
2020
187
0.160
Why?
Cytokines
2
2021
2085
0.160
Why?
Body Temperature
1
2020
222
0.150
Why?
Point Mutation
1
2020
235
0.150
Why?
Haemophilus Vaccines
2
2018
30
0.150
Why?
Insulin Resistance
3
2019
1208
0.150
Why?
Immunocompromised Host
2
2000
202
0.150
Why?
Immunologic Memory
2
2021
353
0.150
Why?
Darunavir
1
2017
19
0.140
Why?
Interleukin-12
1
1998
121
0.140
Why?
Metabolic Syndrome
1
2021
354
0.140
Why?
CD8-Positive T-Lymphocytes
2
2011
900
0.140
Why?
Mycobacterium Infections, Nontuberculous
2
2012
363
0.140
Why?
Therapeutic Equipoise
1
2017
2
0.140
Why?
Dose-Response Relationship, Drug
1
2021
2057
0.130
Why?
Interferon-gamma
5
2012
789
0.130
Why?
Lymphopoiesis
1
2017
26
0.130
Why?
Uganda
1
2017
77
0.130
Why?
Antibody Formation
1
2018
298
0.130
Why?
Immunoglobulin A
2
2017
211
0.130
Why?
Receptors, CCR5
1
2017
56
0.130
Why?
High-Throughput Screening Assays
1
2018
158
0.130
Why?
CD4-CD8 Ratio
1
2016
22
0.130
Why?
HIV-Associated Lipodystrophy Syndrome
1
2016
11
0.130
Why?
Adoption
1
2016
32
0.120
Why?
Mothers
3
2017
754
0.120
Why?
Virus Latency
1
2016
80
0.120
Why?
Cohort Studies
8
2025
5742
0.120
Why?
Continuity of Patient Care
1
2018
284
0.120
Why?
Chickenpox Vaccine
1
2015
73
0.120
Why?
Early Diagnosis
1
2016
242
0.120
Why?
Zimbabwe
2
2025
58
0.120
Why?
Body Height
2
2017
199
0.120
Why?
Gene Products, env
1
1994
6
0.110
Why?
Disease Susceptibility
1
2017
347
0.110
Why?
Adult
15
2023
37929
0.110
Why?
Haemophilus influenzae type b
1
2014
12
0.110
Why?
Bacterial Capsules
1
2014
30
0.110
Why?
Chickenpox
1
2015
83
0.110
Why?
Antibody Affinity
1
2014
60
0.110
Why?
Acquired Immunodeficiency Syndrome
2
2000
230
0.110
Why?
Cote d'Ivoire
2
2025
9
0.110
Why?
Parotitis
1
2014
6
0.110
Why?
South Africa
2
2025
222
0.110
Why?
Vaccines, Synthetic
4
2005
126
0.110
Why?
Developing Countries
1
2016
307
0.110
Why?
Cytotoxicity, Immunologic
3
2002
224
0.110
Why?
Puberty, Delayed
1
2013
9
0.110
Why?
Intestines
1
2017
357
0.110
Why?
Leukocytes, Mononuclear
4
2013
558
0.100
Why?
RNA-Directed DNA Polymerase
1
1993
34
0.100
Why?
Mycobacterium chelonae
1
1993
9
0.100
Why?
Vaccines
1
2018
406
0.100
Why?
Retrospective Studies
8
2023
15657
0.100
Why?
Lipids
1
2017
672
0.100
Why?
Patient Selection
1
2017
696
0.100
Why?
Lamivudine
3
2023
63
0.100
Why?
Colorectal Neoplasms
1
2020
806
0.100
Why?
Breast Neoplasms
1
2025
2253
0.100
Why?
Cell Movement
1
2017
967
0.100
Why?
Mitochondria
2
2021
948
0.090
Why?
Child Development
1
2017
475
0.090
Why?
Pediatric Obesity
1
2019
601
0.090
Why?
Clinical Trials as Topic
1
2017
1050
0.090
Why?
STAT1 Transcription Factor
1
2012
72
0.090
Why?
Cardiovascular Diseases
2
2016
2111
0.090
Why?
Body Fat Distribution
1
2011
49
0.090
Why?
Body Weight
2
2017
985
0.090
Why?
Polysorbates
3
2017
41
0.090
Why?
Prospective Studies
4
2017
7604
0.090
Why?
Mycobacterium avium Complex
1
2012
88
0.090
Why?
Epitopes
2
2022
479
0.090
Why?
Cost-Benefit Analysis
2
2025
591
0.090
Why?
United States
9
2023
14841
0.090
Why?
Biomedical Research
1
2017
692
0.080
Why?
Research Design
1
2017
1139
0.080
Why?
Interleukin-2
2
2003
455
0.080
Why?
Respiratory Tract Infections
1
2014
390
0.080
Why?
Prenatal Exposure Delayed Effects
1
2016
605
0.080
Why?
Exercise
1
2021
2057
0.080
Why?
Freezing
1
2009
90
0.080
Why?
Absorptiometry, Photon
2
2025
259
0.080
Why?
Blood
1
2009
107
0.080
Why?
Algorithms
1
2016
1704
0.070
Why?
Staff Development
1
2009
58
0.070
Why?
Phenotype
1
2017
3196
0.070
Why?
Age Factors
4
2019
3295
0.070
Why?
T-Lymphocyte Subsets
2
2002
417
0.070
Why?
Biomarkers
4
2021
4149
0.070
Why?
Lymphocyte Subsets
2
2009
87
0.070
Why?
Longitudinal Studies
3
2025
2844
0.070
Why?
Specimen Handling
1
2009
183
0.070
Why?
Enzyme-Linked Immunosorbent Assay
2
2021
852
0.070
Why?
Enterovirus A, Human
1
2007
13
0.070
Why?
Faculty
1
2009
147
0.070
Why?
Withholding Treatment
1
2008
76
0.070
Why?
Adipose Tissue
1
2011
635
0.070
Why?
Central Nervous System Viral Diseases
1
2007
79
0.060
Why?
Polymerase Chain Reaction
4
2011
1062
0.060
Why?
Flow Cytometry
3
2009
1178
0.060
Why?
DNA, Viral
2
2000
364
0.060
Why?
Academic Medical Centers
1
2009
512
0.060
Why?
False Negative Reactions
1
2025
53
0.060
Why?
Isoantigens
1
1984
15
0.060
Why?
Cell Line
3
2012
2847
0.060
Why?
Medical Audit
1
2025
78
0.060
Why?
C-Reactive Protein
2
2021
410
0.060
Why?
Enterovirus Infections
1
2007
177
0.060
Why?
Immunity, Cellular
1
2006
268
0.060
Why?
Colorado
3
2023
4565
0.060
Why?
Linear Models
2
2020
849
0.050
Why?
Follow-Up Studies
3
2021
5131
0.050
Why?
Disease Outbreaks
1
2007
395
0.050
Why?
Confusion
1
2024
28
0.050
Why?
Comorbidity
2
2021
1622
0.050
Why?
Sequence Analysis, DNA
2
2007
812
0.050
Why?
Thymus Gland
1
1984
312
0.050
Why?
Tablets
1
2023
40
0.050
Why?
Constriction, Pathologic
1
2024
245
0.050
Why?
Regression Analysis
2
2021
1024
0.050
Why?
Risk Factors
4
2021
10388
0.050
Why?
Respiratory Syncytial Viruses
1
2022
54
0.050
Why?
Genes, T-Cell Receptor beta
1
2002
22
0.050
Why?
Immunophenotyping
2
1994
318
0.050
Why?
Zidovudine
2
2015
78
0.050
Why?
Clone Cells
1
2002
265
0.050
Why?
Dose-Response Relationship, Immunologic
1
2001
82
0.050
Why?
Cough
1
2022
122
0.050
Why?
Emtricitabine
1
2023
175
0.050
Why?
Vaccines, Subunit
1
2001
49
0.040
Why?
Pyridones
1
2023
168
0.040
Why?
Tenofovir
1
2023
243
0.040
Why?
Clinical Trials, Phase I as Topic
1
2021
50
0.040
Why?
Lung
1
2014
4060
0.040
Why?
Ganciclovir
1
2000
53
0.040
Why?
Public Health Surveillance
1
2021
82
0.040
Why?
Computer Simulation
1
2005
978
0.040
Why?
Adjuvants, Immunologic
2
2017
226
0.040
Why?
Africa
1
2020
108
0.040
Why?
Injections, Subcutaneous
1
2020
157
0.040
Why?
Diagnostic Tests, Routine
1
2021
110
0.040
Why?
Symptom Assessment
1
2021
128
0.040
Why?
Sex Factors
2
2019
2071
0.040
Why?
Cross-Sectional Studies
3
2021
5472
0.040
Why?
HIV Seronegativity
1
2019
28
0.040
Why?
HLA-D Antigens
1
1999
34
0.040
Why?
Risk
1
2021
912
0.040
Why?
Case-Control Studies
2
2019
3556
0.040
Why?
Cytomegalovirus Infections
1
2000
192
0.040
Why?
Prevalence
2
2016
2734
0.040
Why?
Lymphocyte Culture Test, Mixed
1
1998
50
0.040
Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2018
25
0.040
Why?
Cytotoxicity Tests, Immunologic
1
1998
41
0.040
Why?
Vaccines, Combined
1
2018
48
0.040
Why?
Cholesterol, HDL
1
2019
203
0.040
Why?
Poliovirus Vaccine, Inactivated
1
2018
28
0.040
Why?
Hospitals
1
2023
691
0.040
Why?
Amino Acid Sequence
1
2002
2139
0.040
Why?
Hepatitis B Vaccines
1
2018
45
0.040
Why?
Odds Ratio
1
2021
1070
0.040
Why?
Mutation
3
2018
3958
0.040
Why?
Drug Resistance, Microbial
2
2000
71
0.040
Why?
Colon
1
2020
282
0.040
Why?
Molecular Sequence Data
1
2002
2900
0.030
Why?
Nutrition Surveys
1
2019
266
0.030
Why?
Case Management
1
2018
66
0.030
Why?
Antigens, Viral
1
1998
178
0.030
Why?
Cholesterol
1
2019
410
0.030
Why?
Cholesterol, LDL
1
2019
365
0.030
Why?
Epitopes, T-Lymphocyte
1
1998
181
0.030
Why?
Immune Tolerance
1
1999
363
0.030
Why?
Treatment Adherence and Compliance
1
2017
26
0.030
Why?
Triglycerides
1
2019
524
0.030
Why?
Reproducibility of Results
1
2005
3284
0.030
Why?
Disease Management
1
2021
628
0.030
Why?
Lymphocyte Count
2
2009
148
0.030
Why?
Cell Division
1
1998
794
0.030
Why?
Uncertainty
1
2017
128
0.030
Why?
Treatment Failure
1
2017
356
0.030
Why?
Multicenter Studies as Topic
1
2017
310
0.030
Why?
Nevirapine
1
2015
17
0.030
Why?
Seroepidemiologic Studies
1
2015
165
0.030
Why?
Time-to-Treatment
1
2017
205
0.030
Why?
Maternal Exposure
1
2017
190
0.030
Why?
Patient Outcome Assessment
1
2016
131
0.030
Why?
Genes, pol
1
1994
7
0.030
Why?
Malnutrition
1
2016
83
0.030
Why?
Randomized Controlled Trials as Topic
1
2021
1477
0.030
Why?
Coinfection
1
2016
137
0.030
Why?
Antiviral Agents
1
2000
744
0.030
Why?
Vaccines, Conjugate
1
2014
65
0.030
Why?
Neutropenia
1
2015
146
0.030
Why?
Counseling
1
2018
391
0.030
Why?
Treatment Outcome
2
2021
10811
0.030
Why?
Sexual and Gender Minorities
1
2018
214
0.030
Why?
Cells, Cultured
2
2008
4193
0.030
Why?
Global Health
1
2017
386
0.030
Why?
Anemia
1
2015
170
0.030
Why?
Maternal-Fetal Exchange
1
2014
165
0.030
Why?
Electron Transport Complex IV
1
2013
60
0.030
Why?
Electron Transport Complex I
1
2013
41
0.030
Why?
Medication Adherence
1
2017
467
0.030
Why?
Thrombocytopenia
1
2015
200
0.030
Why?
Tuberculosis, Cutaneous
1
1993
3
0.030
Why?
HIV Reverse Transcriptase
1
1993
31
0.030
Why?
Radiography, Thoracic
1
2014
167
0.030
Why?
CD8 Antigens
1
1993
75
0.030
Why?
Severity of Illness Index
1
2021
2828
0.020
Why?
CD3 Complex
1
1993
106
0.020
Why?
Drug Administration Schedule
2
2008
786
0.020
Why?
Oxidative Phosphorylation
1
2013
193
0.020
Why?
Lymphocytes
1
1994
397
0.020
Why?
DNA, Mitochondrial
1
2013
200
0.020
Why?
P-Selectin
1
2011
28
0.020
Why?
Blood Pressure
1
2019
1786
0.020
Why?
E-Selectin
1
2011
57
0.020
Why?
Blood Transfusion
1
1994
325
0.020
Why?
Heteroduplex Analysis
1
2011
1
0.020
Why?
Tuberculosis, Pulmonary
1
1993
141
0.020
Why?
Pandemics
1
2020
1639
0.020
Why?
Antigens, CD
1
1994
521
0.020
Why?
Chemokine CCL2
1
2011
115
0.020
Why?
Hospitalization
1
2021
2199
0.020
Why?
Hyperlipidemias
1
2011
120
0.020
Why?
Cell Proliferation
2
2009
2475
0.020
Why?
Fibrinogen
1
2011
168
0.020
Why?
Protein Multimerization
1
2012
192
0.020
Why?
Interferon-alpha
1
2012
198
0.020
Why?
Nontuberculous Mycobacteria
1
1993
205
0.020
Why?
Cell Adhesion Molecules
1
2011
181
0.020
Why?
Healthcare Disparities
1
2017
654
0.020
Why?
Cross Infection
1
1993
256
0.020
Why?
Infant, Premature
1
1994
574
0.020
Why?
Pokeweed Mitogens
1
2009
7
0.020
Why?
Diagnosis, Differential
1
2014
1483
0.020
Why?
L-Selectin
1
2009
24
0.020
Why?
Human Experimentation
1
2009
13
0.020
Why?
Tetanus
1
2009
25
0.020
Why?
Candida
1
2009
38
0.020
Why?
Leukocyte Common Antigens
1
2009
87
0.020
Why?
Obesity
1
2021
2992
0.020
Why?
Multivariate Analysis
1
2011
1509
0.020
Why?
Meningitis, Aseptic
1
2007
13
0.020
Why?
Virus Cultivation
1
2007
29
0.020
Why?
Phosphorylation
1
2012
1759
0.020
Why?
Interleukin-6
1
2011
778
0.020
Why?
Pregnancy Outcome
1
2010
416
0.020
Why?
Cerebrospinal Fluid
1
2007
92
0.020
Why?
Data Interpretation, Statistical
1
2009
363
0.020
Why?
Paralysis
1
2007
71
0.020
Why?
Multiple Organ Failure
1
2007
128
0.020
Why?
B-Lymphocytes
1
2012
847
0.020
Why?
Kinetics
1
2010
1670
0.020
Why?
Respiratory System
1
2007
157
0.020
Why?
Genotype
1
2011
1916
0.020
Why?
Immunoglobulin A, Secretory
1
2005
9
0.020
Why?
Cell Survival
1
2009
1120
0.020
Why?
Phosphates
1
1987
182
0.020
Why?
Muscles
1
1987
326
0.020
Why?
Encephalitis
1
2007
136
0.020
Why?
Gastrointestinal Tract
1
2007
195
0.010
Why?
Mucous Membrane
1
2005
125
0.010
Why?
Chemistry, Physical
1
1984
37
0.010
Why?
Antigen-Antibody Reactions
1
1984
55
0.010
Why?
Chemical Phenomena
1
1984
83
0.010
Why?
DNA-Binding Proteins
1
2012
1502
0.010
Why?
Myasthenia Gravis
1
1984
23
0.010
Why?
Immunologic Deficiency Syndromes
1
1984
69
0.010
Why?
Saliva
1
2005
242
0.010
Why?
Tissue Distribution
1
1984
332
0.010
Why?
Tomography, X-Ray Computed
1
2014
2691
0.010
Why?
Aging
2
2003
1864
0.010
Why?
Epithelium
1
1984
313
0.010
Why?
Blood Glucose
1
2013
2186
0.010
Why?
Body Mass Index
1
2011
2389
0.010
Why?
Middle Aged
2
2020
33479
0.010
Why?
Infusions, Intravenous
1
2003
413
0.010
Why?
Anti-Bacterial Agents
1
1993
1809
0.010
Why?
Reference Values
1
2003
816
0.010
Why?
Mice, Inbred BALB C
1
1984
1272
0.010
Why?
Suspensions
1
2000
36
0.010
Why?
Capsules
1
2000
38
0.010
Why?
Urban Population
1
2003
479
0.010
Why?
Drug Tolerance
1
2000
105
0.010
Why?
Cytomegalovirus
1
2000
157
0.010
Why?
Signal Transduction
1
2012
5079
0.010
Why?
Administration, Oral
1
2000
816
0.010
Why?
Epithelial Cells
1
1984
1096
0.010
Why?
Immunization
1
2000
411
0.010
Why?
Time Factors
1
2008
6828
0.010
Why?
Recombinant Proteins
1
2000
1353
0.010
Why?
Macrophages
1
1984
1547
0.010
Why?
Tail
1
1987
28
0.000
Why?
Mice
1
1984
17787
0.000
Why?
Phosphocreatine
1
1987
46
0.000
Why?
Salamandridae
1
1987
33
0.000
Why?
Animals
2
1987
36940
0.000
Why?
Aged
1
1984
23961
0.000
Why?
Adenosine Triphosphate
1
1987
491
0.000
Why?
Magnetic Resonance Spectroscopy
1
1987
611
0.000
Why?
McFarland's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)